Training Opportunity: “Human Induced Pluripotent Stem Cells and Their Differentiation into Endoderm and Lung-Progeny” at Boston Medical Center (April 9-13, 2018)

The Center for Regenerative Medicine (CReM) at Boston University Medical Center is offering a five-day course that will focus on deriving, maintaining, characterizing and differentiating human induced pluripotent stem cells (hiPSCs). Small class size will enable researchers to learn the entire process of reprogramming from somatic cell preparation, to reprogramming methodologies, iPSC identification, isolation and characterization, and current approaches to their directed differentiation into endodermal and lung lineages.

Registrations will be capped at 10 on a first come, first served basis. To register, please contact Marianne James, PhD (mfjames@bu.edu).

The PCTC Administrative Coordinating Center is pleased reimburse the course registration fee, room and board, for accepted PCTC applicants. Accepted PCTC applicants will be responsible for their travel expenses which may be reimbursed through their PCTC Research Hubs. For pre-approval of reimbursement, please complete the attached application form and email it to Ling Tang (litang@som.umaryland.edu) and Michael Terrin (mterrin@som.umaryland.edu).

For more information, click on the link below:

https://www.bu.edu/dbin/stemcells/files/iPSC%20Training%20Course%20Ad.pdf

If you have any questions about PCTC support this training course, please contact Dr. Terrin or me. Direct questions about the course or its content to Dr. Marianne James or Darrell Kotton, MD.

 

 

Copyright ©2016 NHLBI Progenitor Cell Translational Consortium.

University of Maryland School of Medicine logo

National Heart Blood and Lung Institute logo